Vimarsana
Biggest News Aggregation in the World

Page 4 - Mitchell Cohen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mitchell Cohen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mitchell Cohen Today - Breaking & Trending Today

Urbanfund Corp. Announces Loan to Shareholder - Vimarsana News

Urbanfund Corp. Announces Loan to Shareholder

TORONTO, March 28, 2024 -- Urbanfund Corp. , announces that it entered into loan agreement dated March 27, 2024 pursuant to which the Company has agreed to loan Westdale Construction Co. Limited ...

Happy Anniversary! First Saturday Arts Market marks 20 years with city proclamation - Vimarsana News

Happy Anniversary! First Saturday Arts Market marks 20 years with city proclamation

If you live in and around the Heights, love art or are an artist yourself, if you've ever picked up a copy of The Leader, or stopped by the First

Rx Rundown: Vertex Pharmaceuticals, Vaxcyte, Cardinal Health and more - Vimarsana News

Rx Rundown: Vertex Pharmaceuticals, Vaxcyte, Cardinal Health and more

Check out this week’s medical marketing news, people on the move and industry chatter.

CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO - CytoDyn (OTC:CYDY) - Vimarsana News

CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO - CytoDyn (OTC:CYDY)

VANCOUVER, Washington, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for

CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO - Vimarsana News

CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO

VANCOUVER, Washington, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ('CytoDyn' or the 'Company'), a biotechnology company develo...